Register entry

Lilly France

Registered sites
0
Drug products
16
Live patents
0
Countries
0
Base
Unknown
Sites

Facilities

0

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Catalogue

Marketed products

16

Showing 16 of 16.

BrandGeneric nameFormCategory
-DonanemabINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-DulaglutideINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-DulaglutideINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-Insulin glargineINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-Insulin humanINJECTION, SUSPENSIONDRUG FOR FURTHER PROCESSING
-Insulin humanINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-Insulin humanINJECTION, SUSPENSIONDRUG FOR FURTHER PROCESSING
-Insulin lisproINJECTION, SUSPENSIONDRUG FOR FURTHER PROCESSING
-Insulin lisproINJECTION, SUSPENSIONDRUG FOR FURTHER PROCESSING
-Insulin lisproINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-Insulin lisproINJECTION, SUSPENSIONDRUG FOR FURTHER PROCESSING
-Insulin lisproINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-Insulin lisproINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-Pemetrexed disodiumINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONDRUG FOR FURTHER PROCESSING
-Pemetrexed disodiumINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONDRUG FOR FURTHER PROCESSING
-Raloxifene hydrochlorideTABLETDRUG FOR FURTHER PROCESSING
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.